Typhoid fever screening: Difference between revisions
Jump to navigation
Jump to search
m (Bot: Removing from Primary care) |
Aysha Aslam (talk | contribs) No edit summary |
||
| Line 1: | Line 1: | ||
__NOTOC__ | __NOTOC__ | ||
{{Typhoid fever}} | {{Typhoid fever}} | ||
{{CMG}}; {{AE}}{{ | {{CMG}}; {{AE}}{{AAA}} | ||
==Overview== | ==Overview== | ||
Latest revision as of 02:40, 18 July 2021
|
Typhoid fever Microchapters |
|
Diagnosis |
|---|
|
Treatment |
|
Case Studies |
|
Typhoid fever screening On the Web |
|
American Roentgen Ray Society Images of Typhoid fever screening |
|
Risk calculators and risk factors for Typhoid fever screening |
Editor-In-Chief: C. Michael Gibson, M.S., M.D. [1]; Associate Editor(s)-in-Chief: Aysha Aslam, M.B.B.S[2]
Overview
There are no screening guidelines for typhoid fever. However, chronic carriers can be screened using ELISA to detect antibodies against the Vi antigen.[1][2]
Screening
There are no screening guidelines for typhoid fever. However, chronic carriers can be screened using ELISA to detect antibodies against the Vi antigen.[2]
References
- ↑ http://www.uspreventiveservicestaskforce.org/
- ↑ 2.0 2.1 Lanata CF, Levine MM, Ristori C, Black RE, Jimenez L, Salcedo M; et al. (1983). "Vi serology in detection of chronic Salmonella typhi carriers in an endemic area". Lancet. 2 (8347): 441–3. PMID 6192305.